ロード中...

Gap Junction Enhancer Increases Efficacy of Cisplatin to Attenuate Mammary Tumor Growth

Cisplatin treatment has an overall 19% response rate in animal models with malignant tumors. Increasing gap junction activity in tumor cells provides the targets to enhance antineoplastic therapies. Previously, a new class of substituted quinolines (PQs) acts as gap junction enhancer, ability to inc...

詳細記述

保存先:
書誌詳細
主要な著者: Shishido, Stephanie N., Nguyen, Thu A.
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2012
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3441663/
https://ncbi.nlm.nih.gov/pubmed/23028705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0044963
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!